Collegium Pharmaceutical (COLL) Net Margin Growth (3y) (2019 - 2026)
Powered by 
Analysis
Collegium Pharmaceutical (COLL) Net Margin Growth (3y) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | -204.00 |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 666.00 |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 3,167.00 |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 240.00 |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -1,956.00 |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | -1,144.00 |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 1,366.00 |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | -94.00 |
| 10 | Collegium Pharmaceutical | 753.09 Mn | 603.77 Mn | 110.29 Mn | -1,713.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,713.00 |
| Mar 31, 2026 | 1,953.00 |
| Dec 31, 2025 | 1,337.00 |
| Sep 30, 2025 | 1,469.00 |
| Jun 30, 2025 | 1,058.00 |
| Mar 31, 2025 | 1,696.00 |
| Dec 31, 2024 | 9,838.00 |
| Sep 30, 2024 | -435.00 |
| Jun 30, 2024 | -7,574.00 |
| Mar 31, 2024 | -6.00 |
| Dec 31, 2023 | 1,221.00 |
| Sep 30, 2023 | 84.00 |
| Jun 30, 2023 | -73.00 |
| Mar 31, 2023 | -1,263.00 |
| Dec 31, 2022 | -215.00 |
| Sep 30, 2022 | 873.00 |
| Jun 30, 2022 | 208.00 |
| Mar 31, 2022 | -259.00 |
| Dec 31, 2021 | -10,387.00 |
| Sep 30, 2021 | 3,372.00 |